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angiography1. Stroke e a heterogenous group of vascular diseases
Patients with acute ischemic stroke are heterogenous with
respect to etiology, which makes targeted treatment challenging.
Most trials investigating strategies for stroke prevention have tar-
geted patients with stroke of presumed atherothrombotic (small-
artery occlusion and large-artery atherosclerosis), or cardioembolic
origin. Additionally, some rare causes of stroke are well deﬁned
such as single-gene and mitochondrial disorders. The ﬁve major
categories of the TOAST (Trial of ORG 10172 in Acute Stroke Treat-
ment) classiﬁcation are large-artery atherosclerosis, including
large-artery thrombosis and artery-to-artery embolism; car-
dioembolism; small-artery occlusion; stroke of other determined
cause; and stroke of undetermined cause [1]. Thus, cerebrovascular
atherosclerosis only accounts for a subgroup of ischemic strokes.
However, overt atherosclerotic vascular disease beyond cerebro-
vascular lesions including coronary artery disease (CAD) predicts
deaths and future major cardiac events [2e4].
2. The scope of the problem
The prevalence of coronary artery disease in stroke patients is
substantial. Amarenco and colleagues found a high prevalence of
coronary atherosclerosis based on coronary angiography data in aDOI of original article: http://dx.doi.org/10.1016/j.atherosclerosis.2014.10.102.
http://dx.doi.org/10.1016/j.atherosclerosis.2014.11.010
0021-9150/© 2014 Published by Elsevier Ireland Ltd. This is an open access article undelarge series of consecutive patients with a nonfatal cerebral
infarction and no previously known coronary heart disease. Coro-
nary plaques on angiography were present in 61.9% of patients and
diameter stenosis more than 50% was found in 25.7% of stroke
patients [5]. This study included patients largely irrespective of the
cause of stroke.
A French study based on systematic 64-section computed to-
mography coronary angiography shows that almost 20% of patients
between 45 and 75 years of age with non-disabling, non-car-
dioembolic ischemic stroke or transitory ischemic accident (TIA)
have asymptomatic coronary artery disease (CAD) deﬁned as cor-
onary diameter stenosis of 50% or more [6]. The results of the
present study by Hur and colleagues [7] with a prevalence of
obstructive CAD (coronary diameter stenosis of 50% or more) based
on coronary computed tomography angiography assessment of 48%
corroberate and extend previous ﬁndings.3. Prognostic value of coronary artery calcium scores (CACS)
and coronary computed tomography angiography (CCTA)
Computed tomographic measurements of coronary-artery cal-
cium scores (CACS) predict coronary heart disease independently of
traditional coronary risk factors [8e11]. A doubling of the calcium
score increased the estimated probability of both major coronary
events includingmyocardial infarction and coronary death, and any
coronary event by approximately 25% during 4 years follow-up [12].
Beyond CACS, coronary computed tomographic angiography
(CCTA)-deﬁned extent and severity of coronary artery disease has
been shown to be associated with all-cause mortality [13,14].4. What is the prognostic value of coronary artery calcium
scores (CACS) and coronary computed tomography
angiography (CCTA) in individuals with stroke
Previous studies investigating stroke patients for coronary ar-
tery disease used either non-invasive testing, coronary computed
tomography (CCT), or invasive coronary angiography [5,6]. CCTA is a
non-invasive test characterized by high accuracy when compared
to invasive coronary angiography [15]. However, no previous trial
has investigated the prognostic value of CCTA in stroke patients. In
this issue of Atherosclerosis, the study by Hur et al. [7] provides for
the ﬁrst time, data on the prognostic utility of CCT in patients withr the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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one clinical risk factor for coronary artery disease were prospec-
tively included and followed for about 13 months. CCT scans were
assessed for CAC, presence and extent of CAD. The primary com-
bined endpoint included cardiac death, nonfatal myocardial
infarction, unstable angina requiring hospitalization, or revascu-
larization beyond 90 days following the index CCTA.
Any amount of coronary artery calcium on CCT was present in
73.1% of all patients. Despite the low number of endpoints (only a
total of 26 major adverse cardiac events) the authors could
demonstrate that the presence and extent (1-vessel disease (VD), 2-
VD, and3-VD)of obstructiveCAD(deﬁndedas50%diameter stenosis
or more), independently predicted the risk of future events [7].
However, this intriguing ﬁnding should be considered hypoth-
esis generating and has to be conﬁrmed in further studies. Impor-
tant shortcomings regarding design and conduction of the study
deﬁnitely preclude ﬁnal conclusions and clinical recommendations
at this stage. Some of these shortcomings are mentioned in the
paper and include the small number of outcome events with no
cardiac deaths and only two non-fatal myocardial infarctions [7].
The outcome was entirely driven by “weak” endpoints (unstable
angina requiring hospitalization, and revascularizations). Some of
these events (in particular revascularisation procedures) may have
been triggered by CCTA results.Fig. 1. Coronary artery disease (CAD) detection by CACS and CC5. Predictive value of coronary computed tomography
angiography beyond traditional risk factors and coronary
artery calcium scoring
Current evidence do not support a predictive value of CCTA over
and beyond the CACS and the Framingham risk score (FRS), among
unselected asymptomatic individuals without stroke [16]. Howev-
er, the prognostic value of CCTA may differ for asymptomatic pa-
tients, when stratiﬁed by CACS severity. Recently, a large multi-
centre observational registry could demonstrate that CCTA may
provide incremental prognostic utility for prediction of mortality
and non-fatal myocardial infarction only for asymptomatic in-
dividuals with moderately high CACS, but not for lower or higher
CACS [17].
No previous trial has investigated the prognostic value of
CCTA over CACS and FRS among patients with ischemic stroke.
Hur and colleagues found that the presence of obstructive CAD
and the number of involved vessels assessed by CCTA improved
risk stratiﬁcation beyond clinical risk factors and CACS [7].
Based on the limitations regarding design and conduction of
this study mentioned above, this ﬁnding has to be considered
hypothesis generating and has to be conﬁrmed in further trials
or registries.TA for risk stratiﬁcation in patients with ischemic stroke.
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Because unrecognized CAD is prevalent in patients with carotid
artery disease, current scientiﬁc statements recommend evaluation
for CAD in selected stroke patients with high cardiovascular risk
proﬁles in the presence of signiﬁcant carotid artery lesions [18].
Additionally, regardlessof stroke subtype, patientswithhighCAD risk
based on Framingham risk calculations should also be considered for
such evaluation. In contrast, current recommendations suggest that
stroke patients with fewer vascular risk factors and without signiﬁ-
cant carotid artery disease and patients with stroke subtypes that are
not clearly related to atherosclerosismaybe at lower risk for presence
of coronary artery disease and coronary events and routine testing is
not recommended on the basis of available evidence [18].
The present study by Hur and colleagues suggest a high preva-
lence of CAD in selected stroke patients with CAD risk factors [7].
Surprisingly, Framingham risk score was no indepedent predictor
of outcome events in this study. The authors do not provide in-
formation about patients with stroke subtypes that are not clearly
related to atherosclerosis such as cardioembolism. No information
is available about differences in prevalence of CAD and outcome
between stroke patients with presumed atherothrombotic or car-
dioembolic origin [7].
It remains unclear if the incremental risk stratiﬁcation beneﬁt of
CCT ﬁndings in ischemic stroke patients without chest pain may
translate in improvedoutcomes. Future large randomized trialswith
much longer follow up have to be performed to estimate the po-
tential inﬂuence of CCT ﬁndings on treatment strategies (including
pharmacotherapy [19] and revascularisation procedures) to opti-
mize management and outcomes of patients with ischemic stroke.
Additionally, lifetime attributable risk of cancer after a single
radiation exposure from 64-slice computed tomographic coronary
angiography has to be taken into consideration when patients are
exposed to such diagnostic procedures in the absence of any proven
outcome beneﬁt [20,21].
In conclusion, based on current evidence, CCT screening for CAD
in unselected asymptomatic individuals after ischemic stroke
cannot be recommended and current guidelines (as mentioned
above) stay valid until results from future large trials on optimi-
zation of management and outcomes of stroke patients stratiﬁed by
CCT are available [18] Fig. 1.
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